Next Article in Journal
Prospective Cohort Study of the Kinetics of Specific Antibodies to SARS-CoV-2 Infection and to Four SARS-CoV-2 Vaccines Available in Serbia, and Vaccine Effectiveness: A 3-Month Interim Report
Next Article in Special Issue
Neutralizing Antibodies against SARS-CoV-2, Anti-Ad5 Antibodies, and Reactogenicity in Response to Ad5-nCoV (CanSino Biologics) Vaccine in Individuals with and without Prior SARS-CoV-2
Previous Article in Journal
A Review of Australian Tick Vaccine Research
Previous Article in Special Issue
Increased Risk of Urticaria/Angioedema after BNT162b2 mRNA COVID-19 Vaccine in Health Care Workers Taking ACE Inhibitors
 
 
Article

Article Versions Notes

Vaccines 2021, 9(9), 1028; https://doi.org/10.3390/vaccines9091028
Action Date Notes Link
article xml file uploaded 16 September 2021 15:32 CEST Original file -
article xml uploaded. 16 September 2021 15:32 CEST Update -
article pdf uploaded. 16 September 2021 15:32 CEST Version of Record https://www.mdpi.com/2076-393X/9/9/1028/pdf-vor
article supplementary file uploaded. 16 September 2021 15:32 CEST - https://www.mdpi.com/2076-393X/9/9/1028#supplementary
article html file updated 16 September 2021 15:33 CEST Original file -
article xml file uploaded 22 September 2021 10:59 CEST Update -
article xml uploaded. 22 September 2021 10:59 CEST Update https://www.mdpi.com/2076-393X/9/9/1028/xml
article pdf uploaded. 22 September 2021 10:59 CEST Updated version of record https://www.mdpi.com/2076-393X/9/9/1028/pdf
article html file updated 22 September 2021 11:00 CEST Update https://www.mdpi.com/2076-393X/9/9/1028/html
Back to TopTop